|
||||||||||
|
|
|
|
Olympus Group information such as: Company Profile, Investor Relations, CSR and Environmental Activities, Olympus History, and Web Magazine.
The Gyrus ACMI brand of ‘See’ and ‘Treat’ products features a comprehensive portfolio of instruments designed to improve visualization and provide fast, accurate tissue management that is less traumatic to the patient. The benefits of using the Gyrus ACMI portfolio include:
Gyrus ACMI has three proprietary Divisions, each with a specific surgical focus: In addition, in areas where we have no direct market presence we have brought our technology to the market through out-license and manufacturing relationships with third parties. These relationships are grouped together under our Partnered Technologies Division and address the following surgical specialties:
Gyrus ACMI operates primarily out of the United States of America where each Division has a significant salesforce and the majority of manufacturing is carried out. We have a direct presence in countries around the world and work through a global network of Distribution Partners. The Group employs approximately 1600 staff worldwide.
|
|
| Medical Professionals | Patients © 2009 Gyrus ACMI, All Rights Reserved | About Us | Privacy Policy | Contact Us |